288 related articles for article (PubMed ID: 33884755)
1. Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospital.
Demirel Öğüt N; Kutlu Ö; Erbağcı E
J Cosmet Dermatol; 2021 Jul; 20(7):1969-1974. PubMed ID: 33884755
[TBL] [Abstract][Full Text] [Related]
2. Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID-19)?
Gundogdu M; Dere G
J Cosmet Dermatol; 2021 Jun; 20(6):1568-1570. PubMed ID: 33682290
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
[TBL] [Abstract][Full Text] [Related]
4. Telemedicine management of systemic therapy with isotretinoin of patients with moderate-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study.
Moreno-Ramírez D; Duarte-Ferreras MA; Ojeda-Vila T; García-Morales I; Conejo-Mir MD; Fernández-Orland A; Sánchez-Del-Campo AI; Eiris N; Carrizosa AM; Ruiz-de-Casas A; de-la-Torre JM; Herrerías-Esteban JM; Ferrándiz L
J Am Acad Dermatol; 2022 Nov; 87(5):1186-1189. PubMed ID: 35271937
[No Abstract] [Full Text] [Related]
5. Gender disparities in isotretinoin prescribing patterns for pediatric patients before and during practice changes introduced by the COVID-19 pandemic.
Tan AJ; Xia J; Herringshaw E; Mayur O; Iqbal A; Cucka B; Biglione B; Locascio JJ; Kroshinsky D
Pediatr Dermatol; 2023; 40(5):869-872. PubMed ID: 37495565
[TBL] [Abstract][Full Text] [Related]
6. Gender differences in isotretinoin prescriptions during the COVID-19 pandemic at a U.S. academic medical center.
Duan GY; Ruiz de Luzuriaga AM
Arch Dermatol Res; 2023 Apr; 315(3):643-645. PubMed ID: 36149480
[TBL] [Abstract][Full Text] [Related]
7. How are Acne Vulgaris Patients Using Oral Isotretinoin Affected by Covid-19?
Kuş MM; Öztürk P; Bulut T; Kuş C; Güner ME; Nazik H; Mülayim MK
Dermatol Pract Concept; 2022 Jul; 12(3):e2022146. PubMed ID: 36159115
[TBL] [Abstract][Full Text] [Related]
8. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease.
Taylor MT; Margolis DJ; Kwatra SG; Barbieri JS
J Am Acad Dermatol; 2023 Apr; 88(4):841-847. PubMed ID: 36682724
[TBL] [Abstract][Full Text] [Related]
9. Investigation of relapse rate and factors affecting relapse after oral isotretinoin treatment in patients with acne vulgaris.
Demirci Saadet E
Dermatol Ther; 2021 Nov; 34(6):e15109. PubMed ID: 34431590
[TBL] [Abstract][Full Text] [Related]
10. Isotretinoin-induced inflammatory back pain and sacroiliitis in patients with moderate-to-severe acne vulgaris.
Seyman Civelek Ü; Baykal Selcuk L; Aksu Arica D; Capkin E; Yayli S
J Cosmet Dermatol; 2022 Oct; 21(10):4846-4851. PubMed ID: 35092165
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the changes in sebum, moisturization and elasticity in acne vulgaris patients receiving systemic isotretinoin treatment.
Gencebay G; Aşkın Ö; Serdaroğlu S
Cutan Ocul Toxicol; 2021 Jun; 40(2):140-144. PubMed ID: 33978534
[TBL] [Abstract][Full Text] [Related]
12. Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne.
Al-Haddab M; Alhuqayl A; Alsharif H; Alolyet D; Altaleb R
Cutis; 2021 Jul; 108(1):43-45. PubMed ID: 34397358
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D level in patients with moderate-to-severe acne: A case-control study combined with prospective study following oral isotretinoin treatment.
Shrestha S; Agrawal S; Lamsal M
J Cosmet Dermatol; 2022 Oct; 21(10):5127-5133. PubMed ID: 35429216
[TBL] [Abstract][Full Text] [Related]
14. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data.
Paljarvi T; McPherson T; Luciano S; Herttua K; Fazel S
Br J Dermatol; 2022 Jul; 187(1):64-72. PubMed ID: 35174880
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of adverse events varies with the different oral isotretinoin brands in acne treatment: a retrospective observational study.
Soutou B; Sleiman J; Tomb R; Kechichian E; Helou J
Arch Dermatol Res; 2023 Aug; 315(6):1533-1539. PubMed ID: 36656385
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric disorders and suicidal behavior in patients with acne prescribed oral antibiotics versus isotretinoin: Analysis of a large commercial insurance claims database.
Ugonabo N; Love E; Wong PW; Rieder EA; Orlow SJ; Kim RH; Nagler AR
J Am Acad Dermatol; 2021 Oct; 85(4):878-884. PubMed ID: 33727021
[TBL] [Abstract][Full Text] [Related]
17. Systemic isotretinoin therapy in the era of COVID-19.
Abdelmaksoud A; Vestita M; El-Amawy HS; Ayhan E; An İ; Öztürk M; Goldust M
Dermatol Ther; 2020 Jul; 33(4):e13482. PubMed ID: 32358858
[No Abstract] [Full Text] [Related]
18. Choroidal vascular changes in acne patients under isotretinoin treatment.
Sekeryapan Gediz B; Corak Eroglu F; Aydogan M; Aydugan MT; Kilinc Hekimsoy H
Cutan Ocul Toxicol; 2021 Jun; 40(2):125-129. PubMed ID: 33866916
[TBL] [Abstract][Full Text] [Related]
19. Knowledge levels and concerns about oral isotretinoin treatment in the parents of adolescent acne patients.
Kara Polat A; Akin Belli A; Ergun EZ; Manav Bas V; Erdil D; Koku Aksu AE; Gurel MS
Dermatol Ther; 2020 Jul; 33(4):e13669. PubMed ID: 32459383
[TBL] [Abstract][Full Text] [Related]
20. Acne in the first three decades of life: An update of a disorder with profound implications for all decades of life.
Greydanus DE; Azmeh R; Cabral MD; Dickson CA; Patel DR
Dis Mon; 2021 Apr; 67(4):101103. PubMed ID: 33041056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
